智通财经APP获悉，科笛-B(02487)涨超5%，截至发稿，涨5.64%，报9.37港元，成交额850.36万港元。
消息面上，科笛公布，集团用于表皮麻醉手术的CU-30101 (局部外用利多卡因丁卡因乳膏剂)的中国III期临床试验结果获中华医学会第30次皮肤性病学术年会(CSD年会)接受以电子壁报形式展示。该III期临床试验为一项多中心、随机、双盲、阳性药对照、配对设计的临床试验，以评估CU-30101用于表皮麻醉手术局部镇痛的安全性及疗效。
临床试验结果显示，在疗效方面，两侧面部VAS差值(CU-30101侧-Pliaglis侧)均在预设的等效区间范围内，显示CU-30101与Pliaglis镇痛疗效相当，达到主要终点。在安全性方面，CU-30101的整体安全性良好，无重度不良事件或严重不良事件发生。基于该III期临床试验的结果，集团已向国家药监局提交CU-30101的药品上市许可，并于去年7月获受理。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.